Anti-VEGF Real-World Data Market Tracker

Anti-VEGF treatment is given daily.
Qdata® tracks where, down the brand level.

Qdata® Anti-VEGF Market Tracker actively and accurately tracks real-world usage of anti-VEGF (vascular endothelial growth factor) therapies in patients with retinal conditions, down to the brand level.

Quality data on patients who have received anti-VEGF injections to support commercial planning and market forecasting.

Key Data Elements

Intraocular Pressure

MIGS Device Brand

Visual Acuity

Medication

By the Numbers

M+
Total de-indentified patients who recieved anti-VEGF injections
K+
Contributing clinicians
yrs
Average length of follow-up for anti-VEGF patients

About Qdata® Anti-VEGF Market Tracker

Cells in the eyes produce a protein known as VEGF. If the eye cells produce too much of this protein, abnormal blood vessels can grow, leading to vision damage and even vision loss. Anti-VEGF treatment is a medication that counteracts the production of the protein, stopping damage and slowing vision loss. Anti-VEGF injections are administered into the eye by an ophthalmologist and are known as intravitreal injections.

Anti-VEGF real-world data includes patients treated for conditions including age-related macular degeneration, diabetic retinopathy, and other ophthalmic conditions.

The use of real-world data from anti-VEGF treatments in Qdata Anti-VEGF Market Tracker can help life sciences companies better actively and accurately track real-world usage of Anti-VEGF in patients with retinal clinicians. Commercialization teams can track rolling market share, brand usage and brand switching by indication.

As an exclusive analytics and real-world data curation partner with the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight), Verana Health's Qdata Anti-VEGF Market Tracker can provide valuable data pertaining to real-world usage of this treatment.

Evidence in Action

Exclusive Insights into Anti-VEGF Usage

Only found here from the IRIS Registry® (Intelligent Research in Sight).

eye-icon

Accurate and Timely Data

Regularly refreshed data from the same clinical sources with a ~3 week data lag

eye-icon

Granular Market Segmentation Down to the Brand Level

Curated EHR data can be segmented by brand, geography, demographics and more.

person-icon

Custom Data Curation

Need data tailored to your exact study design requirements?

Our purpose-built, fit-for-purpose datasets are designed to support rigorous research and confident decision-making. These datasets can be tailored
around custom inclusion and exclusion criteria, in addition to including all standard abstracted data elements.

database-icon

Ready to Explore the Anti-VEGF Market Tracker?

Connect with our team to discuss your research objectives and receive a tailored data overview.